Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine-Reference-Cited by-同舟云学术

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

Published:2010-04-05 Issue:16 Volume:107 Page:7473-7478
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Blum W.,Garzon R.,Klisovic R. B.,Schwind S.,Walker A.,Geyer S.,Liu S.,Havelange V.,Becker H.,Schaaf L.,Mickle J.,Devine H.,Kefauver C.,Devine S. M.,Chan K. K.,Heerema N. A.,Bloomfield C. D.,Grever M. R.,Byrd J. C.,Villalona-Calero M.,Croce C. M.,Marcucci G.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference32 articles.

1. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

2. Age and acute myeloid leukemia

3. Gene Silencing in Cancer in Association with Promoter Hypermethylation

4. Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies

5. Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Cited by 421 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythroid Predominance in Bone Marrow Biopsies of Acute Myeloid Leukemia Patients after Decitabine Treatment Correlates with Mutation Profile and Complete Remission;Pathobiology;2024-04-20

2. Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

3. Decitabine versus intensive chemotherapy induction for older patients with acute myeloid leukaemia: a futile but successful trial;The Lancet Haematology;2023-11

4. 10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial;The Lancet Haematology;2023-11

5. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen;Clinical Epigenetics;2023-10-26